deoxyglucose has been researched along with Squamous Cell Carcinoma of Head and Neck in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Knudson, CM; Kowalski, CE; Love-Homan, L; Orcutt, KP; Parsons, AD; Simons, AL; Sobhakumari, A | 1 |
Dang, CV; Hajjar, S; Ishida, Y; Le, AD; Shi, H; Tang, X; Xu, Q; Zhang, Q | 1 |
Davis-Malesevich, M; Fokt, I; Frederick, MJ; Myers, JN; Ow, TJ; Pickering, CR; Priebe, W; Sandulache, VC; Zhou, G | 1 |
Dwarakanath, BS; Sharma, PK; Varshney, R | 1 |
4 other study(ies) available for deoxyglucose and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
Topics: Animals; Antineoplastic Agents; Autophagy; Carcinoma, Squamous Cell; Carrier Proteins; Cell Line, Tumor; Chloroquine; Deoxyglucose; Endoplasmic Reticulum; ErbB Receptors; Erlotinib Hydrochloride; Female; Glucose; Head and Neck Neoplasms; Humans; Membrane Proteins; Mice; Mice, Nude; Protein Kinase Inhibitors; Squamous Cell Carcinoma of Head and Neck; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Transcription Factor CHOP; Xenograft Model Antitumor Assays | 2016 |
EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; CD24 Antigen; Cell Line, Tumor; Deoxyglucose; Dose-Response Relationship, Drug; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; ErbB Receptors; Female; Glycolysis; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; Lactic Acid; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplastic Stem Cells; Phenotype; Phosphatidylinositol 3-Kinase; Polycomb Repressive Complex 1; Retinal Dehydrogenase; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Xenograft Model Antitumor Assays | 2017 |
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
Topics: Adenosine Triphosphate; Carcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Deoxyglucose; Disease Progression; Genes, p53; Glucose; Glutamine; Head and Neck Neoplasms; Humans; Lactic Acid; Mass Spectrometry; Metabolomics; Metformin; Neoplasms, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Suppressor Protein p53 | 2011 |
Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells.
Topics: 6-Aminonicotinamide; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Deoxyglucose; Drug Synergism; Gamma Rays; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured | 2012 |